HER2 and cancer :: mechanism, testing, and targeted therapy /
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science,
©2011.
|
| Schriftenreihe: | Cancer etiology, diagnosis, and treatments.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (xii, 245 pages) : illustrations (some color) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781611222746 1611222745 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn777549432 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 120221s2011 nyua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d OCLCF |d NLGGC |d OCLCO |d EBLCP |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d D6H |d OCLCO |d AGLDB |d OCLCO |d OCLCA |d VNS |d OCLCQ |d VTS |d TOF |d OCLCO |d REC |d OCLCO |d STF |d OCLCO |d AU@ |d OCLCQ |d K6U |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 9781611222746 |q (electronic bk.) | ||
| 020 | |a 1611222745 |q (electronic bk.) | ||
| 020 | |z 9781611226508 | ||
| 020 | |z 1611226503 | ||
| 035 | |a (OCoLC)777549432 | ||
| 050 | 4 | |a RC280.B8 |b H467 2011eb | |
| 060 | 4 | |a QZ 202 | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 082 | 7 | |a 616.99/44906 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a HER2 and cancer : |b mechanism, testing, and targeted therapy / |c Sophie I. Williams and Christopher E. Rogers, editors. |
| 260 | |a New York : |b Nova Science, |c ©2011. | ||
| 300 | |a 1 online resource (xii, 245 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Cancer etiology, diagnosis and treatments | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer. | |
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Breast |x Cancer |x Genetic aspects. | |
| 650 | 0 | |a HER-2 gene. |0 http://id.loc.gov/authorities/subjects/sh98002673 | |
| 650 | 0 | |a HER-2 protein. |0 http://id.loc.gov/authorities/subjects/sh98002671 | |
| 650 | 2 | |a Drug Delivery Systems | |
| 650 | 2 | |a Receptor, ErbB-2 | |
| 650 | 2 | |a Genes, erbB-2 |0 https://id.nlm.nih.gov/mesh/D018734 | |
| 650 | 6 | |a Sein |x Cancer |x Aspect génétique. | |
| 650 | 6 | |a Gène HR2. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a Breast |x Cancer |x Genetic aspects |2 fast | |
| 650 | 7 | |a HER-2 gene |2 fast | |
| 650 | 7 | |a HER-2 protein |2 fast | |
| 700 | 1 | |a Williams, Sophie I. | |
| 700 | 1 | |a Rogers, Christopher E. | |
| 776 | 0 | 8 | |i Print version: |t HER2 and cancer. |d New York : Nova Science, ©2011 |z 9781611226508 |w (DLC) 2010048854 |w (OCoLC)693560744 |
| 830 | 0 | |a Cancer etiology, diagnosis, and treatments. |0 http://id.loc.gov/authorities/names/n2009183163 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=411412 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3018898 | ||
| 938 | |a EBSCOhost |b EBSC |n 411412 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn777549432 |
|---|---|
| _version_ | 1816881786958905344 |
| adam_text | |
| any_adam_object | |
| author2 | Williams, Sophie I. Rogers, Christopher E. |
| author2_role | |
| author2_variant | s i w si siw c e r ce cer |
| author_facet | Williams, Sophie I. Rogers, Christopher E. |
| author_sort | Williams, Sophie I. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B8 H467 2011eb |
| callnumber-search | RC280.B8 H467 2011eb |
| callnumber-sort | RC 3280 B8 H467 42011EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer. |
| ctrlnum | (OCoLC)777549432 |
| dewey-full | 616.99/44906 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/44906 |
| dewey-search | 616.99/44906 |
| dewey-sort | 3616.99 544906 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04229cam a2200613 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn777549432</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">120221s2011 nyua ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">D6H</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">TOF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">REC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781611222746</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1611222745</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781611226508</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1611226503</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)777549432</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.B8</subfield><subfield code="b">H467 2011eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QZ 202</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039030</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">062000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/44906</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">HER2 and cancer :</subfield><subfield code="b">mechanism, testing, and targeted therapy /</subfield><subfield code="c">Sophie I. Williams and Christopher E. Rogers, editors.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">Nova Science,</subfield><subfield code="c">©2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 245 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer etiology, diagnosis and treatments</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Genetic aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">HER-2 gene.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh98002673</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">HER-2 protein.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh98002671</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Receptor, ErbB-2</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Genes, erbB-2</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D018734</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sein</subfield><subfield code="x">Cancer</subfield><subfield code="x">Aspect génétique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Gène HR2.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">Cancer.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Oncology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Genetic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HER-2 gene</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HER-2 protein</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Sophie I.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rogers, Christopher E.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">HER2 and cancer.</subfield><subfield code="d">New York : Nova Science, ©2011</subfield><subfield code="z">9781611226508</subfield><subfield code="w">(DLC) 2010048854</subfield><subfield code="w">(OCoLC)693560744</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer etiology, diagnosis, and treatments.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2009183163</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=411412</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3018898</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">411412</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn777549432 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:18:16Z |
| institution | BVB |
| isbn | 9781611222746 1611222745 |
| language | English |
| oclc_num | 777549432 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xii, 245 pages) : illustrations (some color) |
| psigel | ZDB-4-EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Nova Science, |
| record_format | marc |
| series | Cancer etiology, diagnosis, and treatments. |
| series2 | Cancer etiology, diagnosis and treatments |
| spelling | HER2 and cancer : mechanism, testing, and targeted therapy / Sophie I. Williams and Christopher E. Rogers, editors. New York : Nova Science, ©2011. 1 online resource (xii, 245 pages) : illustrations (some color) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cancer etiology, diagnosis and treatments Includes bibliographical references and index. Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer. Print version record. Breast Cancer Genetic aspects. HER-2 gene. http://id.loc.gov/authorities/subjects/sh98002673 HER-2 protein. http://id.loc.gov/authorities/subjects/sh98002671 Drug Delivery Systems Receptor, ErbB-2 Genes, erbB-2 https://id.nlm.nih.gov/mesh/D018734 Sein Cancer Aspect génétique. Gène HR2. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Genetic aspects fast HER-2 gene fast HER-2 protein fast Williams, Sophie I. Rogers, Christopher E. Print version: HER2 and cancer. New York : Nova Science, ©2011 9781611226508 (DLC) 2010048854 (OCoLC)693560744 Cancer etiology, diagnosis, and treatments. http://id.loc.gov/authorities/names/n2009183163 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=411412 Volltext |
| spellingShingle | HER2 and cancer : mechanism, testing, and targeted therapy / Cancer etiology, diagnosis, and treatments. Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer. Breast Cancer Genetic aspects. HER-2 gene. http://id.loc.gov/authorities/subjects/sh98002673 HER-2 protein. http://id.loc.gov/authorities/subjects/sh98002671 Drug Delivery Systems Receptor, ErbB-2 Genes, erbB-2 https://id.nlm.nih.gov/mesh/D018734 Sein Cancer Aspect génétique. Gène HR2. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Genetic aspects fast HER-2 gene fast HER-2 protein fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh98002673 http://id.loc.gov/authorities/subjects/sh98002671 https://id.nlm.nih.gov/mesh/D018734 |
| title | HER2 and cancer : mechanism, testing, and targeted therapy / |
| title_auth | HER2 and cancer : mechanism, testing, and targeted therapy / |
| title_exact_search | HER2 and cancer : mechanism, testing, and targeted therapy / |
| title_full | HER2 and cancer : mechanism, testing, and targeted therapy / Sophie I. Williams and Christopher E. Rogers, editors. |
| title_fullStr | HER2 and cancer : mechanism, testing, and targeted therapy / Sophie I. Williams and Christopher E. Rogers, editors. |
| title_full_unstemmed | HER2 and cancer : mechanism, testing, and targeted therapy / Sophie I. Williams and Christopher E. Rogers, editors. |
| title_short | HER2 and cancer : |
| title_sort | her2 and cancer mechanism testing and targeted therapy |
| title_sub | mechanism, testing, and targeted therapy / |
| topic | Breast Cancer Genetic aspects. HER-2 gene. http://id.loc.gov/authorities/subjects/sh98002673 HER-2 protein. http://id.loc.gov/authorities/subjects/sh98002671 Drug Delivery Systems Receptor, ErbB-2 Genes, erbB-2 https://id.nlm.nih.gov/mesh/D018734 Sein Cancer Aspect génétique. Gène HR2. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Genetic aspects fast HER-2 gene fast HER-2 protein fast |
| topic_facet | Breast Cancer Genetic aspects. HER-2 gene. HER-2 protein. Drug Delivery Systems Receptor, ErbB-2 Genes, erbB-2 Sein Cancer Aspect génétique. Gène HR2. HEALTH & FITNESS Diseases Cancer. MEDICAL Oncology. Breast Cancer Genetic aspects HER-2 gene HER-2 protein |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=411412 |
| work_keys_str_mv | AT williamssophiei her2andcancermechanismtestingandtargetedtherapy AT rogerschristophere her2andcancermechanismtestingandtargetedtherapy |